Login / Signup

Association between depression subtypes and response to repeated-dose intravenous ketamine.

C WangY ZhouWei ZhengW LiuY ZhanH LiL ChenB ZhangM WalterM LiM D LiYu-Ping Ning
Published in: Acta psychiatrica Scandinavica (2019)
Our study shows promising results for ketamine as a novel antidepressant preferentially for the treatment of non-melancholic or anxious depression.
Keyphrases
  • depressive symptoms
  • pain management
  • sleep quality
  • major depressive disorder
  • high dose
  • combination therapy
  • bipolar disorder